The immunotherapy drug, Pembrolizumab, is effective in shrinking tumors among metastatic triple negative breast cancer patients as found in a clinical trial.
from Top Health News – ScienceDaily http://bit.ly/2qNSZ7v
from Tumblr http://bit.ly/2qV4klJ
No comments:
Post a Comment